PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Drug GMP Report

KLÖCKNER PENTAPLAST AT PHARMAPACK EUROPE EXPLORING BLISTERPRO® XCEL SUITE OF SERVICES

Montabaur, Germany/Gordonsville, Virginia – February 1, 2016 – Klöckner Pentaplast will present the latest range of pharmaceutical packaging solutions and services a...
Continue Reading →
Drug GMP Report

PCI Pharma Services Showcasing Serialization Expertise at Pharmapack Europe in Paris

Philadelphia, USA – February 1st, 2016. Visitors to Pharmapack Europe will gain more insight to the fast-changing world of Serialization with the expert team from le...
Continue Reading →
Drug GMP Report

Peli BioThermal Showcases New Products At Temperature Controlled Logistics Europe

Innovative new shipper systems and services aimed at setting new standards in the temperature-controlled packaging industry will be launched by Peli BioThermal at Te...
Continue Reading →
UNLOCKING THE HIDDEN VALUE IN PHARMACEUTICAL SUPPLY CHAINS Date: Tuesday 2nd February 2016  Time: 1.00-1.30 pm GMT
Drug GMP Report

UNLOCKING THE HIDDEN VALUE IN PHARMACEUTICAL SUPPLY CHAINS Date: Tuesday 2nd February 2016 Time: 1.00-1.30 pm GMT

    Outlining 2016’s big opportunities Pharmaceutical companies are facing an increasingly crowded marketplace and escalating compliance costs. As ...
Continue Reading →
Drug GMP Report

Axol Bioscience Appoints Chief Scientific Officer

Cambridge, UK, 12 January 2016: Axol Bioscience, a biotechnology company, specialising in the use of stem cell technology to manufacture disease relevant cell based ...
Continue Reading →
Drug GMP Report

FDA approved Investigational New Drug for NBTXR3 in a new clinical study in prostate cancer

aris France, Cambridge MA, USA, January 4th, 2016 - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering novel app...
Continue Reading →
Drug GMP Report

Baby food maker ALETE optimizes production with URESH-pigging-systems

For over 80 years Alete GmbH (www.alete.de) has been known as a manufacturer of children's nutrition. The products are made maintaining the highest standards in the ...
Continue Reading →
Drug GMP Report

APTAR PHARMA PRESENTS A STEP CHANGE IN THE PERFORMANCE OF DF30Plus FOR pMDIs INCORPORATING COC

Louveciennes, France - December 7, 2015 - Aptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech...
Continue Reading →
Drug GMP Report

REGISTRATION NOW OPEN!

Registration is now open for BioWales, the leading UK Life Sciences conference - with a discount of 40% available for early bird registration. This discount runs out...
Continue Reading →
Drug GMP Report

Delivering excellence at every step

Novo Nordisk Pharmatech A/S was established in 1949 as FeF Chemicals, acquired by Novo Nordisk in 1986 and has been part of the pharmaceutical group since then. On 1...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026